Latest filing published 22 May 2024 for Aurinia Pharmaceuticals Inc., €30k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -11.4%Entry US$10.05 · Close at T+365 US$8.90
- -7.8%Entry US$11.92 · Close at T+365 US$10.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
R. Hector MacKay-Dunn: trading record in brief
All filings by R. Hector MacKay-Dunn on record concern Aurinia Pharmaceuticals Inc., in the capacity of board member. The record holds 9 filings, for trades running from 11 May 2021 to 21 May 2024.
Both buying and selling appear: 5 purchases worth €92k, against 2 sales worth €80k. Taken together, the purchases exceed the sales by €12k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant and 1 option exercise. Since January 2024: no purchases and 1 sale on the market.
In size, the median ticket on the buying side is €13k. Of 5 purchases, 5 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 5 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +28.0%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 22 May 2024, reports an open-market sale of €30k in Aurinia Pharmaceuticals Inc. The last purchase on record was published on 11 March 2022, which is 1,705 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to R. Hector MacKay-Dunn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,630 shares@ US$5.7422.0% of flowCommon StockSEC:0001600620-24-000070:0
- 4,818 shares@ US$11.2637.3% of flowCommon StockSEC:0001600620-23-000018:2
- 8,733 sharesCommon StockSEC:0001600620-23-000018:0
- 9,310 shares0Common StockSEC:0001600620-23-000018:1
- 5,000 shares@ US$10.99737.3% of flowCommon StockSEC:0001628280-22-005882:0Canonical exit: 7 Jun 2022 (T+90)
- 1,000 shares@ US$11.145.3% of flowCommon StockSEC:0001628280-21-010163:1Canonical exit: 9 Aug 2021 (T+90)
- 1,400 shares@ US$11.267.6% of flowCommon StockSEC:0001628280-21-010163:2Canonical exit: 10 Aug 2021 (T+90)
- 1,600 shares@ US$11.288.7% of flowCommon StockSEC:0001628280-21-010163:3Canonical exit: 10 Aug 2021 (T+90)
- 500 shares@ US$11.173.4% of flowCommon StockSEC:0001628280-21-010163:0Canonical exit: 9 Aug 2021 (T+90)
9 of 9 declarations
